세계의 무혈청 배지 시장 보고서(2025년)
Serum Free Media Global Market Report 2025
상품코드 : 1824456
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

무혈청 배지 시장 규모는 앞으로 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 12.4%로 28억 1,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 바이오프로세스의 확대, 세포치료의 진보, 규제지원, 줄기세포 연구, 백신 생산 수요에 기인합니다. 예측 기간의 주요 동향에는 기술 혁신, 동물성 성분이 없는 솔루션, 맞춤형 배지 처방, 마이크로캐리어 배양 시스템, 연속 바이오프로세스가 포함됩니다.

향후 5년간의 성장률 12.4%라고 하는 예측은 전회 예측으로부터 0.2%의 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 독일과 덴마크에서 개발된 무혈청 세포 배양 배지의 가격을 상승시켜, 생물학적 제제의 제조가 지연되고 생명공학 연구 부문의 비용이 상승하여 미국의 바이오의약품 제조를 방해할 수 있습니다. 또한 상호관세나 무역마찰 및 제한의 격화에 의한 세계경제 및 무역에 대한 악영향에 의해 그 영향은 보다 광범위하게 미칠 것으로 보입니다.

만성 질환 증가는 무혈청 배지 시장의 확대를 촉진합니다. 만성 질환은 장기간 지속되기 때문에 지속적인 치료가 필요하며 종종 일상 생활이 제한됩니다. 무혈청 배지는 연구자가 특정 세포 유형에 맞게 배지를 조정하고 세포의 최적 성장 조건을 보장할 수 있도록 함으로써 중요한 역할을 합니다. 연구원은 무혈청 배지를 이용하여 혈청 없이 세포종을 배양하거나 특수한 응용을 수행하고 새로운 치료법과 만성질환 치료법의 개발에 도움을 주고 있습니다. 예를 들어 2023년 1월 NCBI가 발표한 예측에 따르면 적어도 하나의 만성질환을 앓고 있는 50세 이상의 인구 수는 2050년까지 99.5%의 대폭적인 급증이 예상되며 2020년 7,152만 2,000명에서 1억 4,266만 명에 이를 것으로 예상됩니다. 따라서 만성 질환의 유병률 증가는 무혈청 배지 시장 성장의 원동력으로 작용합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Serum-free media is a category of cell culture media designed for cultivating cells without the use of animal sera. This approach is adopted in cell culture to mitigate the risk of contamination and enhance control over the physiological responsiveness of the cells.

The primary types of serum-free media include Chinese hamster ovary (CHO) cell media, protein expression media, immunology media, insect cell media, hybridoma media, stem cell media, and chemically defined media. Chinese hamster ovary (CHO) cell media, for example, is a chemically defined, protein-free, and serum-free medium specifically tailored for the proliferation of Chinese hamster ovary (CHO) cells and the expression of recombinant proteins in suspension culture. It finds applications in diverse fields such as biopharmaceutical production, tissue engineering, and regenerative medicine. Users of this type of media include biopharmaceutical companies, clinical research organizations, academic research centers, and various other end-users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The serum-free media research report is one of a series of new reports from The Business Research Company that provides serum-free media market statistics, including the serum-free media industry's global market size, regional shares, competitors with serum-free media market share, detailed serum-free media market segments, market trends and opportunities, and any further data you may need to thrive in the serum-free media industry. This serum-free media market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The serum free media market size has grown rapidly in recent years. It will grow from $1.6 billion in 2024 to $1.76 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to cell culture advancements, regulatory restrictions, demand for biopharmaceuticals, reduction in contamination risk.

The serum free media market size is expected to see rapid growth in the next few years. It will grow to $2.81 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to bioprocessing expansion, cell therapy advancements, regulatory support, stem cell research, demand for vaccine production. Major trends in the forecast period include technological innovations, animal component-free solutions, customized media formulations, microcarrier culture systems, continuous bioprocessing.

The forecast of 12.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. biopharmaceutical production by inflating prices of serum-free cell culture media developed in Germany and Denmark, resulting in delayed biologic drug manufacturing and higher biotech research and department costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of chronic diseases is poised to propel the expansion of the serum-free media market. Chronic diseases endure for extended periods, necessitating continual medical attention and often restricting daily activities. Serum-free media play a crucial role by enabling researchers to tailor the media to specific cell types, ensuring optimal growth conditions for cells. Researchers utilize serum-free media to cultivate cell types or perform specialized applications without serum, aiding in the development of new therapies and treatments for chronic diseases. For instance, projections from the National Center for Biotechnology Information (NCBI) in January 2023 anticipated a substantial surge of 99.5% by 2050 in the number of individuals aged 50 years and older afflicted with at least one chronic illness, climbing from 71.522 million in 2020 to 142.66 million. Thus, the rising prevalence of chronic diseases acts as a driving force behind the growth of the serum-free media market.

The escalating number of clinical trials is anticipated to drive the expansion of the serum-free media market. Clinical trials involve research studies conducted with human participants to assess the safety, efficacy, and/or effectiveness of new medical interventions, treatments, drugs, devices, or therapeutic strategies. Serum-free media contribute to the success of clinical trials by establishing a controlled and defined cell culture environment, ensuring scientific rigor, regulatory compliance, and addressing safety and ethical considerations in cell-based research. For example, data from ClinicalTrials.gov in December 2023 indicated that in 2022, a total of 437,515 clinical trials were registered, with 56,561 successfully completed. By December 20 of the subsequent year, there was an upsurge in both registration and completion figures, with 476,626 trials registered and 61,504 trials already completed. Therefore, the escalating number of clinical trials serves as a driving force behind the growth of the serum-free media market.

Leading companies in the serum-free media market are concentrating on developing innovative products, such as advanced CAR T-cell manufacturing solutions, to enhance cell therapy and cancer treatment progress. CAR T-cell manufacturing involves the process of modifying a patient's own T-cells (a specific type of immune cell) to express a chimeric antigen receptor (CAR) that targets particular cancer cells. For example, in May 2023, Lonza, a pharmaceutical company based in Switzerland, introduced TheraPEAK T-VIVO Cell Culture Medium. This specialized serum-free medium is designed for the growth and maintenance of various immune cell types, with a focus on CAR T-cell manufacturing. Notably, this medium features a chemically defined formulation that is serum-free and of non-animal origin (NAO), which significantly decreases variability and enhances consistency in T-cell culture processes.

Major companies operating in the serum-free media market are prioritizing partnerships to bolster their market profitability. Partnerships in serum-free media involve collaborative agreements and alliances among entities such as biotechnology firms, research institutions, and healthcare organizations, aimed at joint development, manufacturing, or advancement of serum-free cell culture media. For instance, in April 2023, Multus Biotechnology, a US-based manufacturer specializing in livestock farming growth media, partnered with Appleton Woods Limited, a UK-based supplier of laboratory equipment and reagents, to introduce Proliferum LSR. Multus introduced Proliferum LSR, an environmentally sustainable serum-free medium for cell growth, offering researchers consistent and reproducible outcomes while serving as an alternative to Fetal Bovine Serum. Additionally, the collaboration between Multus and Appleton Woods focuses on the exclusive distribution of Multus' Advanced Serum Free media range in the UK, aiming to provide advanced growth media formulations to life science researchers and contribute to the development of the sector. Multus' product portfolio includes Vitronectin, a recombinant human protein that enhances cell attachment and supports normal colony morphology across various cell types.

In November 2022, Angus, a company based in the US, acquired Expression Systems for an undisclosed sum. This acquisition is part of Angus's strategy to strengthen its leadership in the Life Sciences sector by enhancing its product portfolio in specialty cell culture media and related services, particularly within the baculovirus expression platform, thereby increasing customer value throughout all stages of bioprocessing. Expression Systems is a US-based biotechnology company that offers serum-free media.

Major companies operating in the serum free media market include Thermo Fisher Scientific Inc., Danaher Corp., Merck KgaA, FUJIFILM Irvine Scientific Inc., GE HealthCare Technologies Inc., Corning Inc., Lonza Group AG, Illumina Inc., Cytiva, Sigma-Aldrich, Bio-Techne Corporation, Serumwerk Bernburg AG, STEMCELL Technologies Inc., MP Bio medicals LLC, Gemcell Electrical Group., InVitria Inc., Takara Bio Inc., HiMedia Laboratories Pvt. Ltd., PAA Laboratories GmbH, PromoCell GmbH, Cellgenix Gmbh, Biochrom AG, Biological Industries, Pan Biotech GmbH, Biowest SAS, Bovogen Biologicals Pty Ltd, Athena Environmental Sciences Inc., Cell Culture Technologies LLC., BioSpherix Ltd., ZenBio Inc.

North America was the largest region in the serum-free media market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the serum free media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the serum free media market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The serum-free media market consists of sales of xeno-free, protein-free, and benchstable media. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Serum Free Media Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on serum free media market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for serum free media ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The serum free media market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Serum Free Media Market Characteristics

3. Serum Free Media Market Trends And Strategies

4. Serum Free Media Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Serum Free Media Growth Analysis And Strategic Analysis Framework

6. Serum Free Media Market Segmentation

7. Serum Free Media Market Regional And Country Analysis

8. Asia-Pacific Serum Free Media Market

9. China Serum Free Media Market

10. India Serum Free Media Market

11. Japan Serum Free Media Market

12. Australia Serum Free Media Market

13. Indonesia Serum Free Media Market

14. South Korea Serum Free Media Market

15. Western Europe Serum Free Media Market

16. UK Serum Free Media Market

17. Germany Serum Free Media Market

18. France Serum Free Media Market

19. Italy Serum Free Media Market

20. Spain Serum Free Media Market

21. Eastern Europe Serum Free Media Market

22. Russia Serum Free Media Market

23. North America Serum Free Media Market

24. USA Serum Free Media Market

25. Canada Serum Free Media Market

26. South America Serum Free Media Market

27. Brazil Serum Free Media Market

28. Middle East Serum Free Media Market

29. Africa Serum Free Media Market

30. Serum Free Media Market Competitive Landscape And Company Profiles

31. Serum Free Media Market Other Major And Innovative Companies

32. Global Serum Free Media Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Serum Free Media Market

34. Recent Developments In The Serum Free Media Market

35. Serum Free Media Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기